|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.6 USD | +6.67% |
|
-4.19% | -15.79% |
| 06/06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
| 05/06 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
The company expired its plan on September 11, 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.79% | 13Cr | |
| +56.89% | 82TCr | |
| +39.52% | 63TCr | |
| -6.55% | 35TCr | |
| +15.99% | 32TCr | |
| +7.92% | 30TCr | |
| +13.74% | 24TCr | |
| +13.83% | 22TCr | |
| -0.49% | 22TCr | |
| +7.94% | 17TCr |
I-MAB 
